Full Press Release Details
Voting Results of 2022 Annual General Meeting
At Legend Biotech Corporation's (the "Company") annual general meeting of shareholders held on October 14, 2022 (the "AGM"), the Company's shareholders:
A total of approximately 324,090,586 ordinary shares, including those underlying ADSs, representing approximately 96.8% of the ordinary shares issued and outstanding
as of September 13, 2022, the record date, were present in person or by proxy at the AGM. The results of the votes are as follows:
| For | Against | Abstain | ||||||||||||||||||||||
| Resolutions | Votes | % | Votes | % | Votes | % | ||||||||||||||||||
| Reception of Audited Financial Statements | 324,021,470 | 99.979 | % | 1,912 | 0.001 | % | 67,204 | 0.021 | % | |||||||||||||||
| Ratification of appointment of Ernst & Young LLP as Independent Auditor for Fiscal Year 2022 | 324,052,382 | 99.988 | % | 6,026 | 0.002 | % | 32,178 | 0.010 | % | |||||||||||||||
| Election of Directors | ||||||||||||||||||||||||
| Dr. Patrick Casey (Class II) | 321,860,342 | 99.312 | % | 2,194,242 | 0.677 | % | 36,002 | 0.011 | % | |||||||||||||||
| Mr. Philip Yau (Class II) | 319,090,836 | 98.457 | % | 4,964,914 | 1.532 | % | 34,836 | 0.011 | % | |||||||||||||||
| Dr. Fangliang Zhang (Class II) | 323,676,232 | 99.884 | % | 378,250 | 0.117 | % | 36,104 | 0.011 | % | |||||||||||||||
| Authorization of Directors and Officers | 323,789,904 | 99.919 | % | 269,124 | 0.083 | % | 31,558 | 0.010 | % |
*Represents less than 0.001% of Votes.
Dr. Fangliang Zhang, Chairman of the Board of Directors, as the person designated by the Company, was granted a discretionary proxy by JPMorgan Chase Bank, N.A., the
depositary of the ADSs, pursuant to the Deposit Agreement governing the ADSs and the Voting Instruction Card mailed by the depositary to the holders of the ADSs, to vote 14,463,776 ordinary shares underlying ADSs for which no voting instructions were
given by the holders, and he exercised the discretionary proxy to vote in favor of each of the proposals submitted for shareholder approval at the AGM.